- ￥5300
- GeneTex
- 美国
- GTX86939
- 2025年09月24日
- WB, IHC-P
- Rabbit
- Human
企业认证
相关产品推荐更多 >
![FUS antibody [HL2454]](https://custom.dxycdn.com/trademd/upload/pic/2013/11/12/A1383891150.jpg!small.t.1)
![C/EBP alpha antibody [15C8]](https://img1.dxycdn.com/2022/0329/602/3572826612844020453-14.jpg!wh200)
![CD52 antibody [YTH34.5] (FITC)](https://img1.dxycdn.com/2022/0328/509/5137967532344400453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
The antiserum was produced against synthesized peptide derived from human Factor VII (171-220).
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX86939
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB, IHC-P
- 浓度：
Batch dependent (Please refer to the vial label for the specific concentration.)
- 靶点：
Factor VII (cleaved Arg212) antibody detects endogenous levels of fragment of activated FA7 resulting from cleavage adjacent to Arg212.
- 抗体英文名：
Factor VII (cleaved Arg212) antibody
- 抗体名：
Factor VII (cleaved Arg212) 抗体
- 规格：
100 μg
WB analysis of Jurkat cells treated with etoposide using GTX86939 Factor VII (cleaved Arg212) antibody.
IHC-P analysis of human breast carcinoma tissue using GTX86939 Factor VII (cleaved Arg212) antibody. The picture on the right is blocked with the synthesized peptide.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Identification of Mutations in the Human Factor VII Gene
It has been recognized from the early 1800s that activation of coagulation can be initiated by the exposure of subendothelial layers (tissue factor), but it was the 1940s before factor VII (FVII) was included in this event
Neoepitope Antibodies Against MMP-Cleaved and Aggrecanase-Cleaved Aggrecan
in studies determining the contribution of matrix metalloproteinases (MMPs) and aggrecanases to aggrecanolysis. In particular, an antibody to the A374 RGSV N terminus was instrumental in the landmark discovery of the aggrecanases, ADAMTS-4 and ADAMTS-5
Sequencing exon by exon to identify mutations is both laborious and time consuming. Screening techniques have been sought to identify mutations without the need for this. Rapid detection of single base changes have focused on identification
技术资料暂无技术资料 索取技术资料
